华绿生物：10月9日召开董事会会议

Group 1 - The core point of the article is that Hualu Bio announced the convening of its fifth board meeting on October 9, 2025, to review the performance conditions for the third vesting period of its 2022 restricted stock incentive plan [1] - For the year 2024, Hualu Bio's revenue composition is entirely from edible mushrooms, accounting for 100% [1] - As of the time of reporting, Hualu Bio has a market capitalization of 1.8 billion yuan [2]